Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia
Titel:
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia
Auteur:
Marcucci, Guido Byrd, John C. Dai, Guowei Klisovic, Marko I. Kourlas, Peter J. Young, Donn C. Cataland, Spero R. Fisher, Diane B. Lucas, David Chan, Kenneth K. Porcu, Pierluigi Lin, Zhong-Pin Farag, Sherif F. Frankel, Stanley R. Zwiebel, James A. Kraut, Eric H. Balcerzak, Stanley P. Bloomfield, Clara D. Grever, Michael R. Caligiuri, Michael A.